chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a  28 Years  old  Female presenting sent from urgent care to rule out stroke presenting with headache, twitching and tremors of the right upper and lower extremities, and tongue numbness.  The patient mentions that yesterday they received the first dose of the Johnson & Johnson vaccine.  She received the first dose of the modern vaccine in April but had an allergic reaction to it (hives, wheezing, cough, chest pain) so she did not receive the second dose.  She received the first dose of the Johnson & Johnson vaccine at 3:15 PM yesterday and her symptoms began at 5 PM yesterday.  Since their onset the symptoms have remained the same.  Patient has not had similar symptoms in the past.  She has not been diagnosed with COVID-19 infection as of yet.
This serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 330782). A 46-year-old female patient, whose past medical history was not provided, had received on 30 October 2008 at 08:00 am an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2769AA). The site of administration was not provided. Approximately one and a half hours post-vaccination, the patient reported having a continuous dry cough and had developed rhinitis, red watery eyes, sore itchy throat, slight shortness of breath, soreness in her throat with breathing and coughing, especially with coughing. She returned to the clinic and was sent to the emergency room where a CBC w/diff was drawn. A saline lock was placed and the patient received a 1000cc bolus of normal saline. She was also treated with BENADRYL 25mg (IVP), DECADRON 4 mg (IVP) and SOLU-MEDROL 80mg (IVP). Lab results revealed CBC w/diff WBC 15.9 k/uL (increased), neutrophils 85%, (increased), bands 5%, lymphs 9% (increased), eosinophils 0% and basophiles 0%. The patient improved with treatment and was discharged to home in stable condition. The patient recovered (date not provided). Documents held by sender: None.
This spontaneous report as received from a registered nurse refers to a 40 year old patient of unknown gender. Medical history and concurrent conditions were not reported. On 07-JUL-2014, the patient was vaccinated with the first dose of (Oka/Merck) PROQUAD (dose, strength, lot number and expiration date were not reported). Secondary and concomitant therapies were not reported. Nurse reported that the patient, who was greater than the recommended age to receive (Oka/Merck) PROQUAD, received a first dose of (Oka/Merck) PROQUAD on 07-JUL-2014. No adverse symptoms reported. Additional information has been requested.
PATIENT REPORTED A SWOLLEN ARM AND INJECTION SITE. PATIENT STATED THE ARM WAS PARALYZED AND PAINFUL FOR A SHORT TIME
headach, body ache, joints ache, muscle weakness, dizziness, heart rate 110
48 hours after I had an intense sore deltoid. Seven days after I began to have swollen lymph nodes and night sweats.
Around 1915 on 9/21, he began to shake all over. Seemed alert ware, breathing seemed labored. T 100.2. Area red on right thigh where vaccine given. Shaking stopped within 30 minutes.
The patient describes that the evening following the vaccines she felt pain from "head to toe" and "chills". She lied down on the bed and put some sheets over. She then felt immobile and she describes a feeling as an "electric shock". She tried to move to call her husband on the phone (he was in the house but in another room) but she could not reach for the phone. She spent the night awake and felt better in the morning, when she could then move.
Pulsatile Tinnitus is the main problem (left ear). Experienced several months (Mid-May through August) of nasal congestion, post nasal drip, and chest congestion/cough. Pulsatile Tinnitus began in July, with some pain in both ears - diagnosed with and treated for a sinus infection, some loss of smell,  Smell has slowly improved. All other symptoms have left other than the pulsatile tinnitus. Tested for COVID three times during this timeframe- all tests were negative.
I started feeling ill the Thursday after my vaccine, I worked the night shift. Friday morning I was being relieved from my shift, he had informed me that other people had gotten Covid, so I got tested Positive for covid. And I quarantined for a week, I had cough, fever, and flu like symptoms. I had a lingering symptom in my eyes. They were inflamed and red. I ended up having cataracts.
The patient experienced chest pain post vax. This report was received from the patient and has not been confirmed by a physician or other health care professional.
Redness at injection site that was 75 mm long 45 mm wide. Slight tenderness at inj site.
Thirteen flu shots equaled 13 boughts of the flu; Initial information was received on 10-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.   This case involved an unknown age patient who reported that thirteen flu shots equaled 13 boughts of the flu (Influenza), after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, it was reported that thirteen flu shots equaled 13 boughts of the flu (Influenza), unknown latency following the administration of INFLUENZA VACCINE.  No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There would be no information available on batch number for this case.
experienced "Covid Toes" in which they had blisters on their toes. They experienced these blisters for about 5 days after dose #2; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An elderly female patient (not pregnant) received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Breast Cancer" (unspecified if ongoing), notes: several years ago (20+ years ago) ; "Chemotherapy" (unspecified if ongoing); "Mastectomy" (unspecified if ongoing); "Neuropathy of Feet and Hands" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: Feb2021, for COVID-19 immunization. The following information was reported: BLISTER (non-serious) with onset Feb2021, outcome "recovered", described as "experienced "Covid Toes" in which they had blisters on their toes. They experienced these blisters for about 5 days after dose #2". Therapeutic measures were not taken as a result of blister.  Additional information: No covid prior vaccination. Not covid tested post vaccination. Patient underwent chemotherapy several years ago (20+ years ago) for breast cancer and as a result experiences neuropathy in their feet. After receiving the Pfizer Covid Vaccine dose #2 and #3, they experienced "Covid Toes" in which they had blisters on their toes. They experienced these blisters for about 5 days after dose #2 and then experienced milder blisters for just a couple of days after dose #3.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a pharmacist via a company representative and refers to a male patient of an unknown age. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. In approximately 2015 (reported as 2 years ago), the patient in his 60s, was vaccinated with a dose of ZOSTAVAX vial 19400 PFU (dose, route of administration, lot # and expiry date were not reported) for prophylaxis, at the pharmacy. Other suspect therapy included sterile diluent (manufacturer unknown). In approximately August 2017 (reported as 2 months ago), the patient experienced shingles. The pharmacist reported that patient was advised to see a physician. The pharmacist reported that on an unspecified date, the patient was examined by an unspecified physician, who treated the patient with an unspecified dose of VALTREX. No laboratory diagnostic studies were performed. The outcome of the event was recovered, in approximately 2017. The reporter did not assess relatedness between the event and vaccination with ZOSTAVAX and sterile diluent (manufacturer unknown).
Information has been received from a health professional concerning a 26 year old female patient, who on 12-JAN-2007 was vaccinated with the first dose, 0.5ml, IM, of Gardasil (Lot# 655617/1447F). Concomitant therapy included hormonal contraceptives (unspecified). On 12-JAN-2007 the patient developed "a 4mm dimple/scar on her arm." The patient sought unspecified medical attention. Additional information has been requested.
Child experienced chest tightness and complaints of sore throat following FLUMIST. No wheeze with chest auscultation, breath sounds decreased. Color fair. Parent called transported child to PMD received ALBUTEROL via nebulizer and steroid shot-per parent report.
Low-grade fever about 8 hours later has rosy red cheeks and felt hot to touch on forehead  Took Tylenol after discovering and started to cool down and went to bed and the fever broke when I woke up the next day Sore arm 1 day after, went away after 1 day.
Symptoms: Fatigue, Severe Headache, Extreme Thirst Treatment: Extra Strength Tylenol, Rest, Plenty of fluids Time Course: 2 days
This spontaneous report as received from a physician regarding a female patient of unknown age. Medical history and concurrent conditions were not reported. On 02-JUN-2015, the patient received improperly stored PROQUAD (Merck) (lot# K025766, expiry date: 08-JUN-2016, dosing details were not specified) which was stored at 23 Fahrenheit for 27:00 hours. There was no concomitant medication reported. No adverse effects was reported and no product quality complain involved. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine administered 12 APR about 0830 hours and all fine that day.  Next day (13 APR) my father awoke feeling tired, somewhat sluggish and experienced a little diarrhea. 14 APR, still a hint of diarrhea but now tired and with pain in the back of his neck and his body ached all over, but pain was mild and these conditions lasted through 15 APR 21.  No fever or headache observed.  Today he awoke and felt fine, no additional issues to report but will report anything else should it occur.
pain and soreness at the site of injection; she had nausea; Fever; Chills; No appetite; Headache; No energy; she had flu like symptoms; This case was reported by a consumer via and described the occurrence of injection site pain in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2021, the patient received the 1st dose of Shingrix (intramuscular). On 29th August 2021, 5 hrs after receiving Shingrix, the patient experienced injection site pain. On 30th August 2021, the patient experienced nausea, fever, chills, appetite absent, headache and loss of energy. On an unknown date, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the injection site pain, nausea, fever, chills, appetite absent, headache, loss of energy and influenza-like symptoms were recovered/resolved.   The reporter considered the injection site pain, nausea, fever, chills, appetite absent, headache and loss of energy to be related to Shingrix. It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The patient had first shot of Shingrix intramuscularly in her right arm and had flu like symptoms for 3 days. Five hours after receiving the shot patient experienced pain and soreness at injection site. In the morning following the shot patient had nausea, fever, chills, no appetite, headache, and no energy that lasted for 72 hours. The patient received the shot 3 weeks ago and all her symptoms had thus resolved. The patient declined follow up with her healthcare professional. The reporter did not consent to follow up.
She had rubella measles, lasted 7 days. She had some very dangerous and bad spells during this period of time. Follow up: not seen by physician. Diagnosis is mother's.
Swollen face, itchy hives on neck and face, hot to the touch.  This appeared in less than 48 hours from having the shot.
Cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 2021, outcome "unknown", described as "Cold". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had the first dose of the Pfizer vaccine on 12Mar2021 and she was due for the next on 02Apr2021 (tomorrow). She had a question. She had a cold, not a terrible cold and no fever, just a standard cold. The patient had a Covid test this week and she doesn't have it, just a cold. She asked if she should just take it anyway tomorrow or wait until Monday. She was getting better. It was a standard cold.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I suffered a severe vertigo attack - the only one I've ever had. It took me about 6 weeks to fully recover.
All Covid symptoms returned. Tremors. Severe headache. Numbness in right side of face and body. Dizzy.  New was throat swell and tongue swelling.
A report received from a health professional on 11/05/2001, concerning a 30 year old female pt who experienced jaw pain, an injection site reaction and reduced arm movement, 3 days after receiving Fluvirin vaccine on 10/30/2001. On 11/02/2001, the pt experienced left-sided jaw pain, inflammation and pain at injection site, and reduced function of right arm, 3 days after receiving the fluvirin vaccine. At the time of this report, the injection site reaction and arm function had resolved, but the jaw pain was worsening. The pt's condition was deteriorating and she was having difficulty fully opening her jaw. The pt was treated with Analgesics, which had no effect. The pt recovered on 11/16/2001. There was insufficient info to determine the reporter's causality assessment. Followint internal review on 04/12/2002, this event was upgraded to serious.
Inability to flex right side of body at joints;  pain in ankle, leg, arm and hands; slight paralysis in hand; unable to hold pencil.   It was debilitating for 3+ weeks and then seemed to get a little better from the end of February until mid March; made it painful to do my daily (exercise) walking routine only to come back with a vengeance in Mid March in my right foot, ankle, and lower leg and knee.
pt recv 1 dose of varivax in 5/95 & in 4/98 pt devel a chickenpox rash w/vesicles on back & scattered throughout body.
This spontaneous report was received from a nurse refers to a patients with unknown demographics. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy was not provided. On 06-JAN-2016, the patient was vaccinated with an improperly stored dose of PEDVAXHIB (dose, route and frequency: unknown) (lot # L030870, expiry date: 11-JUN-2018). The temperature excursion details for vaccine were as follows: temperature 31.3 degrees Fahrenheit (F), time frame: 3 hours, 5 minutes. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Wed 9/27 flat red circular rash head trunk then spread to arms not itchy, 9/30 cleared, Mon 10/2 started no other s/s, 10/03 bright red larger circular slightly raised rash head trunk arms, 1/04 more rash face spread down legs, on palms, sides of feet no other s/s, 10/05 rash head to toe still visible but very light in color, clearing.
Extreme vertigo, some tinnitus and pressure in head developed the day after I received the shot and persisted on a daily basis. Some episodes multiple times per day.
(L) lung mild ache after (R) deltoid inj. heavy feeling disappeared by ASA.
Pt recvd Hep B vax 415PM @ 440 pt driving 1mil from clinic felt throat closing up; pt presented @ clinic & was given Epi & DPH; pt taken to hosp by ambulance & observed;
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-APR-2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 02-OCT-2014, the patient was treated for a persistent and severe vesicular rash, which was diagnosed as shingles. The patient was prescribed VALTREX for management of her painful symptoms. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Woke at midnight the following day with chills headache and shaking.Very fatigued. No fever. Rested the next day .felt better no fever.but still tired.Next day. (Fri) woke up with swollen neck gland on the left side.Still tired but improving
Woman c/o "itchy feeling on my neck, back and my abdomen about 10 min after receiving vaccine. Hives appearing on left lateral & posterior aspects of neck, right abdominal quadrant and left side of back. No resp. distress or swelling noted.  VS 140/80, AP 80, RESP 20. Woman refusing epinephen, SC. Woman took Benadryl 50 mg. po. 20 min later hives had completely disappeared and "itchy feeling is gone" woman stated.
Swollen lymph nodes under both arms and rash all over body.  Given prednisone and told to take Benadryl.
Achy and sore all over, but mostly at injection point. Mild headache and lack of energy throughout the day. Gone within 24 hours.
Headache 2-3 days; Day 3 the rash began on both legs with blisters, itching, pain, burning sensation appeared to be shingles (I have had shingles previously but no shingles vaccine) Lasted a total of 2.5 weeks until most symptoms were gone. Still have occasional nerve pain and burning.
about 3-5 days after the injection i got a rash below the injection site. it was red, felt hot, burned and itched.it was about 3 inch diameter and a roundish shape.  it was similar, although covered a smaller area than, to the rash i got after my 2nd Moderna covid vaccine. today is 9/15 and it is almost  gone but it?s still visible. still  periodically, slightly, itches. i did not treat it because i didn?t want to interfere with my immune system mounting a response. it was uncomfortable & annoying but did not interfere in my day to day activities. i also got a sore arm which lasted from vaccine date for about 5 days.
At around 3 AM the following morning, my right shoulder (bursitis, probably) was so painful, it woke me up. I have frequent bursitis, probably due to fibromyalgia. It's been coming and going for decades. This was the same kind of pain, only much worse.   I got up, rubbed some smelly muscle cream on it, took a Percocet and a bit of ibuprofen. The pain was relieved fairly quickly and I was able to sleep.  If the vaccine causes fibromyalgia flare-ups or inflammation, this is understandable, but it would be nice to have some stronger anti-inflammatory meds on hand for those of us who have certain conditions.
3x 4 inch oval shaped red area around injection spot. Swelling at red area around injection spot.
A report has been received from a Health Professional concerning a 60 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT (Intranasal) started on 21-Oct-2014. It was reported that there vaccine was administered to wrong patient population which started on 21-Oct-2014. The outcome of the event of administration to wrong patient population is unknown. The reporter's description of the event(s) was as follows: Not provided. The report was considered to be non-serious.
Pt recv vax on unknown day; post vax pt exp transient numbness and could not walk for a few hr
Rash within a few days of initial vaccination.  Rash covered the upper part of both arms and was completely gone within two weeks,  using OTC anti-itch medications.  I declined to take the second shot in the series.  A couple days ago, a rash has returned to my upper right arm. I am using the same OTC medications as the previous rash.
104 degree fever; sick; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received pneumococcal 13-valent conjugate vacccine (dipht crm197 protein) (trade name unspecified, lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, as unknown, single dose, for immunization; and tetanus vaccine (trade name unspecified), via unspecified route of route of administration, on an unspecified date, at an unspecified dose, for immunization. The patient medical history and concomitant medications were not reported. The patient reported that on an unspecified date, she received a pneumonia vaccine shot and had a 104 degree fever for a week and was sick for a week and that went away. She reported that on an unspecified date, she had to get a tetanus vaccine shot and had the same reaction as she did with the pneumonia vaccine. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are needed. No further information is expected.  Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vacccine (dipht crm197 protein) in the country of incidence or the country where the product was purchased. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vacccine (dipht crm197 protein) has submitted the same report to the regulatory authorities.
11-22-19 Client at clinic states arm (L) is swollen and on fire. RN assessed (L) arm red, warm, raised skin. Client said it started 11-20-19 - evening and that it hurts. Traced perimeter of redness with marker told client to go to ER if gets worse. Ice pack applied to irritated area on left arm.